Clinuvel Pharmaceuticals Ltd (FRA:UR9)

€ 7.98 -0.055 (-0.68%) Market Cap: 402.88 Mil Enterprise Value: 289.95 Mil PE Ratio: 19.03 PB Ratio: 3.28 GF Score: 90/100

Full Year 2024 Clinuvel Pharmaceuticals Ltd Earnings Call Transcript
Aug 29, 2024

€9.31 (+12.10%)

Earnings
Full Year 2022 Clinuvel Pharmaceuticals Ltd Earnings Presentation Transcript
Aug 30, 2022
Half Year 2022 Clinuvel Pharmaceuticals Ltd Earnings Call Transcript
Feb 23, 2022

€14.06 (+0.72%)

Earnings
Clinuvel Pharmaceuticals Ltd Corporate Presentation Transcript
Oct 25, 2021
Clinuvel Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Nov 11, 2020

Clinuvel Pharmaceuticals Ltd Annual Shareholders Meeting Transcript

Nov 11, 2020 / 07:00AM GMT

Release Date Price: €12.71 (-2.27%)

Transcript

Willem Blijdorp

Clinuvel Pharmaceuticals Ltd - Non-Executive Chair

Good morning, ladies and gentlemen, and welcome to the 2020 Annual General Meeting of CLINUVEL Pharmaceuticals Limited. My name is Willem Blijdorp, and I'm the Chair of the Board of Directors and the designated Chairperson for today's meeting.

I have been informed by the company secretary, there is a quorum. I declare the meeting open, in response of Australian government restriction, instead of a physical meeting with shareholders, and the Board has decided to conduct the 2020 AGM online. We appreciate your understanding, and thank you for joining us today, and but maybe for some difficult time to join.

I would like to introduce you to the clinical Board today. Joining me from Europe is our Managing Director and CEO, Dr. Philippe Wolgen. Also in attendance, Mrs. Susan Smith, who is joining us from UK and Dr. Karen Agersborg, who is joining us from the USA. From our Melbourne office, Ms. Brenda Shanahan and Professor Jeffrey Rosenfeld as well as our Company Secretary and CFO, Mr. Darren Keamy.

Online, we also

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.